QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Quantify Publishes Paper on Cost-Effectiveness of Patiromer in Combination with RAAS Inhibitors for CKD in Sweden in PharmacoEconomics
The paper ‘Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden’, co-authored by Quantify, has been published in PharmacoEconomics. Read the full article here.
Paper on Real-World Effectiveness of Osteoporosis Treatment in the Oldest Old Published in Osteoporosis International
The paper ‘Real-world effectiveness of osteoporosis treatment in the oldest old’, co-authored by Quantify’s Oskar Ström, Rosa Lauppe, and Gustaf Ortsäter, has been published in Osteoporosis International.
QUANTIFY publishes world’s largest asthma research platform in prestigious European Respiratory Journal
The largest asthma research platform in the world is now live! Last week, QUANTIFY published the article “NORDSTAR – Paving the way for a new era in asthma research” in the ERJ in collaboration with Novartis and the Nordic Severe Asthma Network (NSAN). This milestone in the multiparty research collaboration known as the Nordic Research Dataset For Asthma Research (NORDSTAR) containing […]
Paper on fracture history and imminent fracture risk co-authored by Quantify team published in JBMR
The paper ‘History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55-90 Years Presenting with a Fragility Fracture’, co-authored by Quantify’s Jonas Banefelt and Gustaf Ortsäter, has been published in The Journal of Bone and Mineral Research. See full article here.
